1276: Jiangsu Hengrui Pharmaceuticals Co.,Ltd - Summary | Jitta

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HKG:1276

Price
HK$65.70
Loss Chance
42.2%
7.55JITTA SCORE
158.05%Over Jitta Line
Jitta Ranking
23 / 225
209 / 2,478
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (75)
Recent Business Performance (95)
Financial Strength (93)
Return to Shareholders (58)
Competitive Advantage (77)
Jitta Signs
Revenue and EarningConsistent Growth in the past 3 years
Recent Business PerformanceEarning Growth Last Year
Operating MarginExpansion
Debt LevelLow Long Term Debt
Dividend PayoutEvery year
Interest Coverage RatioVery Good
SG&A to SalesDecreasing Every Year
Recent IPOLess than 3 years
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
7.55
158.05%
4.29
286.37%
3.71
298.72%
Pharmaceuticals
6.49
316.37%
5.59
298.00%
7.32
65.01%
COMPANY DESCRIPTION
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.